At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Argent secures deal for Malta manufacturing facility, unlocking US$1 million in cost savings. ... Read More The post Argent ...

Her goals are to make Piramal Pharma a $2 billion company by 2030 while achieving a 25 per cent EBITDA margin—an aim that ...

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship ...

“All hospitals use GPOs to contract for sterile injectable ... presidency to consider more permanent manufacturing decisions.” Still, some major US pharmaceutical companies have made large ...

Trump has consistently championed the cause of increasing domestic pharmaceutical production and previously vowed to implement tariffs to bolster the country’s manufacturing capacity. Although he ...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to relocate operations to the U.S. He also stated he warned Taiwan Semiconductor ...

Beijing issued a lengthy denunciation of U.S. trade policies and accused Washington of violating a trade deal the countries ...

Trump said this was to avoid "being held hostage" by countries, including China who he described as a "hostile trading nation ...

It is not just about bringing new technologies to pharmaceutical manufacturing, it’s also about making completely new ‘advanced therapies’ ready for production,” he outlined. According to ...